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EDITORIAL
Lipoxygenases in renal injury—Loading the matrix
A matrix of multiple coordinated pathways perpetuates
renal injury. Genetic, hemodynamic, and cellular factors
act together resulting in progression of glomeruloscelrosis
and tubulointerstitial fibrosis, culminating in end-stage re-
nal disease. Many of the actors in this tragedy have been
identified by studies in humans, animal models of renal
disease, and cell culture studies. For instance, in diabetic
nephropathy, the primacy of hyperglycemia was estab-
lished by the salutary effects of glucose control on progres-
sion of renal disease. Success of pharmacologic agents that
interfere with either the production or the cellular actions
of angiotensin II in slowing the progression of a variety
of renal diseases attests to the importance of angiotensin
II in pathogenesis of renal disease. However, the precise
cellular mechanisms by which angiotensin II inflicts harm
are not fully understood. Angiotensin II is versatile and
affects both the hemodynamic and cellular pathways men-
tioned above [1]. Angiotensin II induces cell hypertrophy
and promotes synthesis of extracellular matrix proteins,
processes that are linked to progression of renal disease
[2]. Mechanisms underlying these effects include stimula-
tion of synthesis of growth factors such as transforming
growth factor  [2], transactivation of epidermal growth
factor (EGF) signaling pathway [3], and generation of
free radicals [4]. In this issue of Kidney International, Kim
et al [5] describe yet another mediator of angiotensin II
in cell injury (i.e., products of 12/15-lipoxygenase (LO)
activity).
Generation of prostaglandins from arachidonic acid and
their effects on kidney function are well known. Arachi-
donic acid is also a substrate for another group of enzymes
that catalyze the addition of molecular oxygen at distinct
carbon atoms on the polyunsaturated fatty acid molecule
(i.e., the 5-, 12-, and 15-LOs). LOs generate 5-, 12-, or
15-hydroxyeicosatetraenoic acids (HETEs), of which two
stereoisomers (S and R) exist. Products of 5-, 12/15-LOs
are expressed in renal tissue and may originate in infiltrat-
ing hematopoietic cells or resident renal cells, including
mesangial cells [6]. In rodents, 12/15 LO performs the
functions of 15-LO. Products of 15-LO include 15-(S)-
HETE and, in association with 5-LO, lipoxin A4, which
exert anti-inflammatory effects in experimental glomeru-
lonephritis. Lipoxin A4 antagonizes the effects of leuko-
triene D4 and causes vasodilatation and increase in glo-
merular filtration. Thus, leukotrienes generated by 5-LO
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on the one hand, and 15-HETE and lipoxins on the other,
may play opposing roles in immune-mediated glomerular
injury. Recently, a role for 12/15 LO in non-immune renal
disease has been proposed. Increased mRNA and protein
expression of 12/15-LO was found to be associated with
augmented fibronectin content in glomeruli of rats with
established type 1 diabetes [7]. However, it was unclear
whether this association was casual or causal. Even if
pathogenetically important, where 12/15-LO fits into the
matrix of processes that injure the kidney was not known
and has been addressed by Kim et al [5] in this issue.
Several agents known to be involved in renal injury,
such as high glucose and angiotensin II, share the property
of stimulating the activity of 12/15-LO and generation of
12(S)-HETE in mesangial and vascular smooth muscle
cells. Kim et al [5] explored the role of 12/15-LO in angio-
tensin II- and serum-induced changes in mesangial cell
function that are of importance in renal injury (i.e., synthe-
ses of DNA, total protein, and fibronectin). In contrast
to their effects on wild-type mesangial cells, angiotensin
II and serum failed to stimulate DNA, general protein,
and fibronectin syntheses in mesangial cells from 12/15-
LO knockout mice. The authors explored the signaling
mechanisms involved. Whereas stimulation of fibronectin
synthesis by serum and angiotensin II was associated with
activation of p38 MAP kinase in wild-type mesangial cells,
these effects were absent in 12/15-LO knockout cells. One
mechanism by which p38 MAP kinase regulates gene ex-
pression is by activation of cyclic AMP response element
binding protein (CREB), a transcription factor. While
there was an indication that serum-stimulated increase in
CREB binding to DNA was reduced in 12/15-LO knock-
out cells, this parameter was unaffected by angiotensin II.
Thus, the p38 MAP kinase-CREB axis may apply only
to serum stimulation of fibronectin synthesis in mesangial
cells but not to angiotensin II, which appears to recruit
other pathways for promoting synthesis of the matrix pro-
tein. However, the important observation by the authors
that angiotensin II was fully capable of stimulating Erk-
1/-2 type MAP kinase in 12/15-LO knockout mesangial
cells excludes this pathway as well in angiotensin II stimu-
lation of DNA, protein, or fibronectin syntheses. Having
excluded two important MAP kinase pathways, it will be
interesting to identify signaling pathways that are in-
volved. One obvious choice is the phosphatidylinositol
3-kinase (PI 3-kinase)-Akt pathway, as it has been shown
to be important in stimulation of general protein synthesis
in renal tubular epithelial cells by growth factors such
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as insulin-like growth factor (IGF)-I and vascular endothe-
lial growth factor (VEGF) [8]. PI 3-kinase may be acti-
vated by tyrosine kinases such as receptors for growth
factors including EGF. It would be of interest to examine
if angiotensin II effects depend on intermediary growth
factors such as transforming growth factor (TGF)- or
transactivation of EGF receptor [3]. The PI 3-kinase-Akt
axis regulates protein translation by modulating the phos-
phorylation state of crucial eukaryotic factors and their
binding proteins [9]. Additionally, relevant to the work
reported by Kim et al, TGF-–induced fibronectin synthe-
sis has been found to involve activation of PI 3-kinase
and Akt in mesangial cells [10]. The authors suggest that
failure of DNA synthesis stimulation by serum in 12/15-
LO knockout cells is due to impairment in induction of
c-fos, an early growth response gene. It is not entirely
clear that this is the sole mechanism, as induction of c-fos,
while not as intense in the 12/15-LO knockout cells, was
more prolonged than in the wild-type cells. Together,
these observations suggest an important place of 12/15-
LO in the matrix of processes that leads to cell injury in
mesangial cells. However, more needs to be understood.
For instance, Kim et al [5] showed that generation of
superoxide in resting cells depended on the integrity of
12/15-LO. The relevance of this important pathway to
DNA, protein, or fibronectin syntheses remains to be
shown. This may particularly apply to diabetic renal dis-
ease, as mitochondrial free radical generation has been
proposed as a unifying pathway for target tissue injury
in diabetes [11]. Glutathione depletion promotes nitric
oxide–induced cell death by recruitment of 12-LO path-
way [12]. Glutathione depletion is inimical to target tissues
in diabetes, as it makes them more susceptible to oxidative
injury [11] and occurs when mesangial cells are exposed
to high glucose [13]. This is another potential area for
exploration. As the study by Kim et al [5] employed an
in vitro model, the next logical step should be studies on
evolution of renal disease such as diabetic nephropathy
in 12/15 LO knockout mice.
Discovery of 12/15-LO as a mediator of angiotensin
II–induced mesangial cell injury could be of importance
to diabetic and nondiabetic renal disease, as angiotensin
II antagonists exert salutary effects on both types of renal
disease. This finding also opens up the possibility of phar-
macologically interrupting 12/15 LO pathway as a thera-
peutic strategy. Identification of important constituents
such as 12/15-LO that make up the pathogenic matrix will
help develop comprehensive strategies for interrupting
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